Heart Bypass Surgery
Angiotech and Symphony Medical Announce Licensing Agreement
Published in Medical Device Business Week, January 30th, 2008
Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP) and privately held Symphony Medical, Inc. announced that they have entered into an exclusive licensing agreement to employ one of Angiotech's proprietary PEG-based biomaterials as part of a prophylactic therapy envisioned to mitigate the onset of post-operative atrial fibrillation (POAF) for patients undergoing coronary artery bypass grafting and cardiac valve surgeries.
"This agreement is another example of our continuing effort to lessen the complications and improve the outcomes of patients living with cardiovascular disease," said Dr. Bill Hunter, President and CEO of Angiotech. "Our innovative...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Addiction Medicine
Dominion Diagnostics Sets a New Standard of Care in the Field of Pain Medicine - Arrhythmia
Columbus, Ohio Patients among First in United States to Receive the Sleuth(TM) Wireless Remote Implantable ECG Monitoring System - Atrial Flutter
Speedy Procedures Demonstrate Excitement and Continued Interest in Novel Multi-Electrode Ablation System - Biosense Webster, Inc.
Fully Automated, Irrigated Tip Radiofrequency Ablation System with Remote Navigation Receives FDA Approval - Bipolar Disorder Cell Biology
Findings from RIKEN advance knowledge in bipolar disorder cell biology - Breast Implants
Silicone Breast Implants Making a Comeback - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
